BEYOND MEAT, INC.

Listed Company

BYNDCIK 0001655210NasdaqAcceleratedFood And Kindred ProductsDelawareFY ends Dec 31

Period

FY 2025

Revenue

$275.50M

Net Income

$219.02M

Total Assets

$614.75M

Equity

$-997.0K

Shares Out

463.56M

Op. Cash Flow

$-144.93M

Business

Beyond Meat, Inc. produces plant-based meat products that replicate the taste, texture and sensory attributes of animal-based meats using proprietary scientific processes. It offers plant-based beef, pork, poultry and value-added meal products in ready-to-cook and ready-to-heat formats, formulated from plant-derived proteins, lipids and other ingredients without GMOs, added hormones or antibiotics and with no cholesterol. The company operates a single reportable operating segment centered on innovation, research and manufacturing of plant-based meats. Its products are sold through retail, mass merchandiser, club, natural retailer and foodservice channels across multiple countries worldwide.

Summary from filing dated 2025-03-05

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net revenues	275	326	343	419	465
Cost of goods sold	268	285	426	443	347
Gross profit (loss)	8	42	−83	−24	117
Research and development expenses	23	28	40	62	67
Selling, general and administrative expenses	218	170	204	240	209
Loss on write-down of assets held for sale	49	0	17	—	—
Loss from impairment of long-lived assets	51	0	0	—	—
Restructuring expenses	0	0	−600,000	17	16
Total operating expenses	341	198	259	319	292
Loss from operations	−334	−156	−342	−343	−175
Interest expense	−14	−4	−4	−4	—
Remeasurement of warrant liability	15	0	0	—	—
Remeasurement of derivative liability	−12	0	0	—	—
Gain on debt restructuring, net of exchange fees	549	0	0	—	—
Other, net	15	−10,000	12	−420,000	−487,000
Total other income (expense), net	553	−4	8	−4	−4
Income (loss) before taxes	219	−160	−334	−347	−179
Income tax (benefit) expense	0	−26,000	5,000	32,000	60,000
Equity in losses of unconsolidated joint venture	78,000	73,000	4	19	3
Net income (loss)	219	−160	−338	−366	−182
Less: Earnings allocated to participating securities	−41	0	0	—	—
Net income (loss) available to common stockholdersbasic (in shares)	178	−160	−338	—	—
Net income (loss) per share available to common stockholdersbasic (in dollars per share)	1.15	−2.43	−5.26	−5.75	−2.88
Weighted average common shares outstandingBasic (in shares)	155	66	64	64	63
Net loss per share available to common stockholdersdiluted (in dollars per share)	−1.83	−2.43	−5.26	−5.75	−2.88
Weighted average common shares outstandingdiluted (in shares)	181	66	64	64	63

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2025 2025-09-30	FY 2025 2025-06-30	FY 2024 2024-12-31	FY 2023 2023-12-31
Cash and cash equivalents	204	—	—	132	191
Restricted cash, current	4	—	—	1	3
Accounts receivable, net	26	—	—	27	32
Inventory	84	—	—	113	130
Prepaid expenses and other current assets	14	—	—	11	13
Assets held for sale	9	—	—	2	—
Total current assets	341	—	—	286	373
Restricted cash, non-current	9	—	—	13	13
Property, plant and equipment, net	213	—	—	185	194
Operating lease right-of-use assets	6	—	—	124	130
Prepaid lease costs, non-current	41	—	—	68	62
Other non-current assets, net	3	—	—	622,000	1
Investment in unconsolidated joint venture	2	—	—	2	2
Total assets	615	—	—	678	774
Accounts payable	21	—	—	38	56
Current portion of operating lease liabilities	2	—	—	4	4
Accrued expenses and other current liabilities	9	—	—	12	10
Accrued litigation expenses	39	—	—	0	—
Accrued litigation settlement	0	—	—	7	0
Short-term finance lease liabilities	4	—	—	851,000	—
Total current liabilities	75	—	—	61	74
Delayed draw term loans, net	78	—	—	0	—
Delayed draw term loan warrants at fair value	5	20	20	0	—
Operating lease liabilities, net of current portion	4	—	—	74	76
Finance lease liabilities	77	—	—	3	—
2030 Embedded Derivative liability at fair value	39	—	—	0	—
Other long-term liabilities	220,000	—	—	0	274,000
Total long-term liabilities	541	—	—	1,218	1,213
Commitments and contingencies (Note 12)	—	—	—	—	—
Preferred stock, par value $0.0001 per share500,000 shares authorized, none issued and outstanding	0	—	—	0	0
Common stock, par value $0.0001 per share3,000,000,000 shares and 500,000,000 shares authorized at December 31, 2025 and 2024, respectively; 453,688,312 shares and 76,065,969 shares issued and outstanding at December 31, 2025 and 2024, respectively	45,000	—	—	8,000	6,000
Additional paid-in capital	1,029	—	—	644	573
Accumulated deficit	−1,023	—	—	−1,242	−1,081
Accumulated other comprehensive loss	−8	—	—	−4	−5
Total stockholders deficit	−997,000	—	—	−601	−513
Total liabilities and stockholders deficit	615	—	—	678	774

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Loss from impairment of long-lived assets	51	0	0	—	—
Depreciation and amortization	33	23	48	33	22
Non-cash lease expense	4	8	8	5	3
Share-based compensation expense	31	24	29	34	28
Provision for credit losses	1,000	221,000	0	0	—
Amortization of debt issuance costs and debt discount	5	4	4	—	—
Loss on write-down and sale of fixed assets	49	809,000	21	—	—
Write-down of note receivable	136,000	0	4	0	—
Gain on debt restructuring, net of exchange fees	−558	0	0	—	—
Unrealized (gains) losses on foreign currency transactions	−12	5	−2	5	0
Paid-in-kind interest	5	0	0	—	—
Accounts receivable	2	4	3	9	−8
Inventories	32	16	106	3	−123
Prepaid expenses and other current assets	−5	2	13	12	−21
Accounts payable	−15	−21	3	−11	22
Accrued expenses and other current liabilities	29	5	−2	−7	14
Prepaid lease costs, non-current	−8	−7	−4	−55	−59
Operating lease liabilities	−3	−3	−3	−4	−3
Long-term liabilities	220,000	0	0	—	0
Net cash used in operating activities	−145	−99	−108	−320	−301
Purchases of property, plant and equipment	−12	−11	−11	−70	−136
Proceeds from sale of fixed assets	2	4	4	0	—
Proceeds from note receivable on assets previously held for sale	84,000	0	0	0	0
Payments for investment in joint venture	0	0	−3	−13	−11
Proceeds from security deposits	32,000	435,000	0	−981,000	—
Net cash used in investing activities	−10	−6	−9	−88	−147
Proceeds from issuance of common stock pursuant to the ATM Program, net of issuance costs	149	47	0	0	0
Proceeds from delayed draw term loans, net of issuance costs	100	0	0	—	—
Payment of debt issuance costs	−16	0	0	0	−24
Payment of equity issuance costs	−7	0	0	—	—
Principal payments under finance lease obligations	−3	−1	−223,000	−210,000	−177,000
Proceeds from exercise of stock options	6,000	924,000	170,000	2	8
Payments of minimum withholding taxes on net share settlement of equity awards	−424,000	−695,000	−497,000	−1	−3
Net cash provided by (used in) financing activities	223	46	−550,000	276,000	1,022
Net increase (decrease) in cash, cash equivalents and restricted cash	68	−59	−118	−407	573
Effect of foreign currency exchange rate changes on cash	4	−1	1	−3	694,000
Interest	0	0	0	10,000	348,000
Taxes	0	6,000	−1,000	38,000	−10,000
Issuance of common stock in conjunction with the exchange of 2027 Notes	215	0	0	—	3
Re-classification of prepaid issuance costs to additional paid-in-capital related to ATM program	2	0	0	—	—
Issuance of 2030 Notes in conjunction with the exchange of 2027 Notes, including PIK	334	0	0	—	—
Conversion of 2030 Notes to common stock	3,000	0	0	—	—
Issuance of common stock warrants in connection with delayed draw term loans	17	0	0	—	—
Non-cash additions to property, plant and equipment	551,000	3	909,000	4	5
Issuance costs of convertible debt, accrued not yet paid	187,000	0	0	—	—
Operating lease right-of-use assets obtained in exchange for lease liabilities	2	2	36	37	17
Reclassification of pre-paid lease costs to finance lease right-of-use assets	0	131,000	28	29	0
Reclassification of pre-paid lease costs to finance lease right-of-use assets	20	0	0	—	—
Reclassification of operating lease right-of-use assets to finance lease right-of-use assets	116	0	0	—	—
Non-cash addition to financing leases	10	4	0	280,000	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro